Objective: The primary purpose of this study was to estimate the cost-effectiveness of sequential denosumab/zoledronic acid versus zoledronic acid monotherapy for postmenopausal osteoporotic women in

NIAID Data Ecosystem20

Table_1_Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study.docx

精神分裂症治疗

药物经济学评估

ObjectiveThis study aims to compare the hospitalization rate in individuals with schizophrenia who started their treatment with aripiprazole once monthly (AOM400) or atypical oral antipsychotics (OA)

NIAID Data Ecosystem00

Total cost and difference for groups with and without clazosentan for patients with and without spasms under different treatments.

药物经济学评估

脑血管痉挛治疗成本

Total cost and difference for groups with and without clazosentan for patients with and without spasms under different treatments.

Figshare2026-01-02 更新30

Cost–effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia: supplementary data

药物经济学评估

重症肺炎治疗

Aim: This study evaluates the cost–effectiveness of imipenem/cilastatin/relebactam (IMI/REL) for treating hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VAB

NIAID Data Ecosystem10

Costs in Focus: A Pharmacoeconomic Comparison of Vaccine Prices for Immunization

资源简介：

相关数据集